PER® Spectives

PER Spectives

Science EN ↓ 57 episodes

Physicians' Education Resource® (PER®) is committed to advancing patient care through professional education. This podcast is a natural extension of PER®'s efforts to provide medical education for health care providers to stay up to date with advances in medical care, from diagnosis through treatment, with the ultimate goal of improving patient outcomes. Visit http://www.gotoper.com for more information.

Author

PER® Spectives

Category

Science

Podcast website

audioboom.com

Latest episode

Aug 28, 2025

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 5M+ downloads · 4.8 rating iOS soon

Episodes

S2 Ep23: Oncology PER® Spectives™: PSMA in Prostate Cancer: Precision Medicine in Imaging & Therapy 09.01.2025
S2 Ep22: PsychPearls Podcast: Optimizing the Management of Tardive Dyskinesia – Addressing the Complexity of Care with Targeted Treatment 19.12.2024

Tardive dyskinesia (TD), a neurological disorder characterized by involuntary movement, is commonly associated with exposure to antipsychotic medication. The disorder can have significant impacts on patient quality of life due to functional challenges and social stigmatization. Comprehensive assessment of TD burden and severity is needed to guide treatment decisions and optimize outcomes. In this...

S2 Ep21: Burst CME™: Tackling Adverse Events with Targeted Therapies for Diffuse B-cell Lymphoma 09.12.2024
S2 Ep20: Burst CME™: Tackling Adverse Events with Targeted Therapies for Diffuse B-cell Lymphoma 09.12.2024
S2 Ep19: Burst CME™: Treating Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Current Options and Emerging Approaches 03.12.2024
S2 Ep18: Biomarkers in Diffuse Large B-cell Lymphoma: Empowering Treatment Decisions to Improve Outcomes 25.11.2024
S2 Ep17: Mind Moments™: Optimizing Management for Patients with Generalized Myasthenia Gravis 15.11.2024
S2 Ep16: Patient, Provider, & Caregiver Connection: Individualizing Care in Hemophilia A to Optimize Joint Health and Prevent Synovitis 13.09.2024
S2 Ep15: PER®Spectives: Advancing Treatment in nAMD and DME with Novel Therapies 01.02.2024

This PER ® Spectives™ podcast examines opportunities for extended treatment intervals associated with newer therapies for patients with neovascular age-related macular degeneration or diabetic macular edema. In this podcast, experts Arshad Khanani, MD, Ferhina Ali, MD, and Michael Singer, MD, offer real-world data and personal insights into the use of these agents — and corticosteroid implants for...

S2 Ep14: Postpartum Depression: A Multidisciplinary Approach to Management 20.12.2023

This podcast explores the diagnosis and management of postpartum depression with a focus on the importance of screening all postpartum women and treatment options. Two faculty, Sarah Nagle-Yang, MD , and Lindsey Lebin, MD , discuss the importance of an early diagnosis with each other, and a patient shares her journey living with postpartum depression. Faculty Lindsay Lebin, MD Assistant Professor...

S2 Ep13: Patient, Provider, and Caregiver Connection™: Developing Strategies to Improve Patient Access to Care for Thalassemia - Understanding Patient Challenges and the Role of Innovative Treatment 20.12.2023

This podcast explores the management of thalassemia with a focus on the disease burden, current therapy, and emerging gene therapy.  Two faculty, Hanny Al-Samkari, MD, and Kevin H.M. Kuo, MD, MSc, FRCPC, discuss with each other and with a patient sharing their journey living with thalassemia. Faculty Hanny Al-Samkari, MD Classical Hematologist and Clinical Investigator Division of Hematology Oncol...

S2 Ep12: Generalized Myasthenia Gravis: Improving Patient Outcomes Through Early Diagnosis and Management 05.12.2023

This podcast features engaging commentary from experts in the clinical management of generalized myasthenia gravis— James Howard, Jr, MD and Nicholas Sylvestri, MD. These experts discuss the burden of disease associated with the disorder, its pathogenesis in terms of the complement system, and the clinical considerations for incorporating appropriate targeted therapy to improve health-related outc...

S2 Ep11: Advances in Topical Treatment for Presbyopia 31.08.2023

This PER ® Spectives™ podcast examines treatment of presbyopia with a focus on new and emerging topical therapies. In this podcast, experts Mile Brujic, OD, FAAO, and  Jay Pepose, MD, PhD, describe these agents and how to select patients with presbyopia who will benefit from topical treatment. Faculty: Mile Brujic, OD, FAAO Premier Vision Group Bowling Green, OH Jay Pepose M.D., Ph. D. Pepose Visi...

S2 Ep10: Multidisciplinary Perspectives on Saving Sight—The Expanding Role of the Optometrist in Retinal Disease Care 30.08.2023

Optometrists play a critical role in first-line screening and monitoring of patients with neovascular age-related macular degeneration (or nAMD) and diabetic macular edema (or DME). Where patients require more advanced care, optometrists refer them to retina specialists. Join Drs Ferhina Ali, Carl Regillo, Jessica Steen and Mohammad Rafieetary as they review the role of optometrists in managing re...

S2 Ep9: Clinical Pearls in Co-Managing Glaucoma 16.08.2023

This PER® Spectives™ featured podcast examines the important role of co-management of glaucoma between optometrists and ophthalmologists .Expert faculty review the selection of traditional and novel topical therapies, and also patient selection for micro-incisional glaucoma surgery (MIGS).  Faculty Danica J. Marrelli, OD, FAAO, AAO   College of Optometry, University of Houston Houston, TX Alena Re...

S2 Ep8: Advances in Treatment for Geographic Atrophy 14.08.2023

This podcast provides a review of some of the key highlights from the Controversies in Modern Eye Care meeting held in April 2023. The program is designed for those who did not attend the live meeting and to help reinforce learnings for those who did. Faculty David S. Boyer, MD Retina-Vitreous Associates Medical Group Los Angeles, CA Tina Mac Donald, OD, CDCES, FAAO WesternU Health Los Angeles Los...

S2 Ep7: Looking at the Lid – Reducing Patient Burden in Blepharoptosis & Demodex Blepharitis 18.07.2023

Welcome to a podcast based on learning about the lid: optimizing recognition, diagnosis, and treatment of Demodex Blepharitis and Blepharoptosis.  In this podcast, we will hear from Dr Mile Brujic and Dr Cecelia Koetting. Faculty Mile Brujic, OD, FAAO Partner Premier Vision Group Bowling Green, OH Cecelia Koetting, OD, FAAO, DipABO Optometrist Denver, CO

S2 Ep6: Thyroid Eye Disease: The Masquerading Eye Disorder - A Guide to Accurate Diagnosis & Collaborative Care 11.07.2023

In this episode, four expert faculty talk about the importance of early diagnosis and treatment of thyroid eye disease. They discuss the differential diagnosis, screening tests, and the need for multidisciplinary management for these patients. Faculty Steven Leibowitz, MD Associate Clinical Professor, Oculoplastics and Orbit Jules Stein Eye Institute UCLA School of Medicine Los Angeles, CA Raymond...

S2 Ep5: Considerations for Customizing Care Plans for Patients with Parkinson Disease Psychosis 07.07.2023

In this podcast, two experts discuss the diagnosis and treatment of Parkinson disease psychosis. In their conversation, they discuss examples of patients they have encountered. They also discuss the results of recent clinical trials of new therapies and the importance of a multispecialty approach for these patients. Faculty Gus Alva, MD, DFAPA Medical Director, Senior Brain Health Hoag Hospital As...

S2 Ep4: Catching and Addressing Early Neurotropic Keratitis: New Perspectives 26.06.2023

Neurotrophic keratitis (NK) is a rare condition caused by trigeminal nerve damage, which results in decreased or absent corneal sensitivity and breakdown of the corneal epithelium. If not recognized and managed appropriately, it can lead to corneal ulceration and loss of vision. However, early diagnosis and treatment can improve outcomes. This featured podcast includes an interview with an optomet...

S2 Ep3: Facing the Changing Landscape for Neuromodulators and Dermal Fillers 15.02.2023

Thanks for your interest in this podcast. Please read this important program information before listening. Access to the posttest and instructions for claiming credit for participating are included below. This PER® Spectives™ podcast examines the recent increase in the demand for dermal fillers and neuromodulators, and the corresponding increase in the number of products available for health care...

S2 Ep2: Addressing Healthcare Inequities™: Tailoring Management Plans to Address Healthcare Disparities in Cystic Fibrosis 03.02.2023

Thanks for your interest in this podcast. Please read this important program information before listening. Access to the post-test and to claim credit for participating is included below. This PER® Spectives™ podcast includes a discussion with 3 experts on health disparities that negatively impact patients with cystic fibrosis (CF). Access to care, insurance costs, and unintended bias are just som...

S2 Ep1: MGD-Associated Dry Eye Disease – How Emerging Options May Shift the Treatment Paradigm 31.01.2023

Meibomian gland dysfunction (MGD) is a complex, multifactorial disorder that can lead to altered tear film composition and ocular surface disease. In fact, MGD is one of the most common causes of dry eye disease (DED). Although multiple treatment options are available, therapies that target the underlying pathophysiology of the disease are lacking. Emerging agents with novel mechanisms for treatin...

S1 Ep9: Advances in Sickle Cell Disease Management 31.01.2023

This podcast features engaging commentary from experts in the clinical management of patients with sickle cell disease:  Nirmish Shad, MD from Duke University Medical Center, Matthew Heeney, MD Matthew Heeney, MD from Harvard Medical School, and Charles R. Jonassaint, PhD, MHS from University of Pittsburgh School of Medicine. These experts review clinical guidelines, interpret clinical data regard...

S1 Ep8: Part 1 of 5: Top 10 Oncogenic Markers in NSCLC for 2022: An interview with Dara Aisner MD, PhD 17.08.2022

Our ever-advancing understanding of oncogenic drivers in non–small cell lung cancer (NSCLC) has led to an expanding armamentarium of targeted therapy options. Given the availability of recently emerging, highly efficacious treatments, it is more important than ever that patients with NSCLC undergo comprehensive testing to identify targetable alterations. Many therapies are currently available or u...

Listen to the PER Spectives podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.